Eko is a healthcare technology company that focuses on providing innovative solutions for cardiac or pulmonary conditions. They offer products and software that enable healthcare professionals to monitor, diagnose, and treat patients remotely.
Eko was founded in 2013.
In 2015, they launched their first product, the Eko Core, a smart stethoscope that can record and analyze heart sounds.
In 2019, Eko partnered with the Mayo Clinic to develop an algorithm for early detection of heart failure.
In 2020, they received FDA clearance for Eko DUO, a digital stethoscope with integrated electrocardiogram capabilities.
Eko has raised significant funding from investors like Mayo Clinic, Artis Ventures, and Questa Capital.
Zoll Medical is a leading provider of medical devices and software solutions for emergency care, including cardiac resuscitation.
Nuubo is a company that offers wearable ECG monitoring systems to detect and prevent cardiovascular diseases.
Withings is a health technology company known for its range of connected devices, including smartwatches and health monitors.
A digital stethoscope with integrated electrocardiogram capabilities for enhanced cardiac assessment.
A smart stethoscope that records and analyzes heart sounds, enabling remote cardiac monitoring and diagnosis.
Artificial intelligence software that assists healthcare professionals in the analysis and interpretation of cardiac data.
Eko is a healthcare technology company that offers innovative solutions for remote cardiac monitoring and diagnosis.
The Eko Core is a smart stethoscope developed by Eko that records and analyzes heart sounds, enabling remote monitoring and diagnosis.
The Eko DUO is a digital stethoscope with integrated electrocardiogram capabilities, allowing for enhanced cardiac assessment.
Eko AI is an artificial intelligence software developed by Eko that assists healthcare professionals in the analysis and interpretation of cardiac data.
Eko's competitors include Zoll Medical, Nuubo, and Withings, among others.